Fundraising FoxACON Bios Investors
Washington, US · Founded 2018 · Canada (Federal Level) limited partnership
Find your way into ACON Bios Investors
Sign up to see every warm intro you have to ACON Bios Investors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ACON Bios Investors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KL
Kwame LewisNamed on SEC filing
TY
Teresa Y. BernsteinNamed on SEC filing
JK
Jose KnoellManaging Director of the General Partner of the Issuer.
Reported raises · per SEC filings
Form D private placements$25M disclosed across 1 round · 2018
▶$25MraisedDec 2018 · 2 investors · BiotechnologyRule 506(b)
▶$25MraisedDec 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kwame LewisExecutive Officer
- Jose KnoellExecutive Officer
- Teresa Y. BernsteinExecutive Officer
- ACON Bios GenPar, L.L.C.Promoter
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Dec 2018
- Incorporated
- Limited Partnership, Canada (federal Level), 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ACON Bios Investors raised?
- ACON Bios Investors has disclosed $25M raised across 1 round.
- Where is ACON Bios Investors headquartered?
- ACON Bios Investors is headquartered in Washington, US.